
    
      Objectives:

      Primary To investigate the effect of early use of EVL plus TAC dose reduced vs. MPS plus TAC
      full dose on CMV infection by antigenemia 12 month after transplantation in stable kidney
      transplant recipients.

      Secondaries

      To evaluate renal function by cGFR (MDRD) To evaluate the incidence of acute rejection and
      nephrotoxicity by protocol biopsies; To evaluate the incidence of poliomavirus, according to
      treatment group, by quantitative PCR the BKviremia in urine and biopsy sample.
    
  